Recherche
-
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
(PLoS Pathogens. vol. 16, n° 6, pp. e1008522, 2020-06-26)Article de revueLibre accès -
Randomized Trial of Vaccines for Zaire Ebola Virus Disease
(New England Journal of Medicine. vol. 387, pp. 2411-2424, 2022-12-29)Article de revue